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Standard surgical treatment of abdominal aortic
aneurysm (AAA) consists of replacing the aneurysm
by means of graft interposition with or without
resection of the aneurysmal pouch. Dubost et al1 in
1952 described retroperitoneal resection and homo-
graft replacement of AAA. Intraluminal graft suture
without resection of the aneurysmal sac was popu-
larized by Creech2 and became the standard proce-
dure. This method of treatment has been shown to
improve life expectancy, though the overall elective
mortality rate is between 2% and 5%.3-6
Endoluminal management of AAA has been pro-
posed as an alternative to the standard procedure for
patients at high surgical risk.7-10 The technique is
transarterial placement of an aortic stent graft to
exclude completely the aneurysmal sac. This method,
however, has its limitations. First, the shortness of
the proximal aortic neck precludes stable anchoring
of the proximal part of the endograft. When the
endograft is not anchored properly, the stent graft
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Purpose: To describe an exclusion endoluminal technique for management of abdominal
aortic aneurysms among high-risk patients with complex anatomic features.
Methods: From January 1995 to December 1996, among 143 patients with infrarenal
abdominal aortic aneurysm treated by means of endograft placement, 9 (6.3%) had com-
plex aortic or aortoiliac morphologic features. For these patients, the endograft was
delivered through a femoral cutdown in an occluding aortoiliac configuration. The con-
tralateral iliac artery was occluded with an iliac endograft. Axillofemoral bypass grafting
was performed. Computed tomographic scans were obtained regularly. 
Results: There was 1 postoperative death of severe arrhythmia. All aneurysms were found
to be affected by thrombosis on immediately postoperative computed tomographic
scans, except in 1 patient with a proximal leak, which was managed successfully with
angiographic embolization. The mean follow-up time was 12 months. Aortic aneurysm
diameter decreased from 2 mm at 6 months (2 patients) to 6 mm at 12 months (6
patients). All axillofemoral bypass grafts are patent.
Conclusions: Placement of an occluding endograft associated with axillofemoral bypass
grafting is a good alternative for patients at high risk with complex anatomic features.
Longer-term follow-up study is needed to evaluate this endoluminal technique. (J Vasc
Surg 1998;28:651-6.)
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dislodges and proximal leakage occurs.10,11 Second,
correct placement can be difficult in the presence of
a complex aortic or aortoiliac anatomic configura-
tion. For patients with this AAA morphologic char-
acteristic, we performed extra-anatomic axillofemoral
bypass combined with placement of an occluding
endograft. We describe our experience with 9
patients and present their follow-up findings.
METHODS 
Selection of patients. The nine patients were
selected from 143 patients who underwent aortic
endoluminal stent grafting for management of AAA
from January 1995 to December 1996. All patients
were in compassionate care status (class 3 or 4 of the
American Anesthesiology Association classification).
The six men and three women had an average age of
75 years (range, 68 to 85 years). Seven patients were
older than 70 years. All patients had at least 2 asso-
ciated pathologic conditions (Table I). All these
infrarenal aortic aneurysms presented complex mor-
phologic features, as follows: short length of the
infrarenal aortic portion (proximal neck) with or
without tortuous proximal neck or iliac arteries. The
decision to implant an occluding endograft com-
bined with extra-anatomic axillofemoral bypass was
made in view of the difficult access for endoluminal
treatment and the high risk of conventional surgical
treatment.
Procedure. Aneurysm diameter was determined
by means of spiral computed tomographic (CT)
scanning for all patients. Preoperative digital sub-
straction angiography was performed only when
there were no contraindications (4 patients, 46%).
All aneurysms were infrarenal with an average diam-
eter of 6.4 ± 0.8 cm (range, 5.3 to 7.6 cm).
The Corvita stent graft (Corvita Europe,
Brussels, Belgium) is composed of 2 components—
a self-expandable metallic stent made of a double
helix of paired wires of elgyloy and a coating of 600
layers of polycarbonate urethane fibrils (Corethane)
bound to the inner wall of the metallic stent by
means of an adhesive glue of polycarbonate ure-
thane. The devices are available in standard sizes
(total length 14 cm and diameters of 14, 16, 27, 40,
or 45 cm). They can be cut to the required length
during the operation.
Under general anesthesia, extra-anatomic
axillofemoral bypass was performed at the beginning
of the operation for 6 patients (66%) with 8-mm
diameter externally supported polytetrafluoroethyl-
ene (PTFE) prosthesis (IMPRA, Tempe, Ariz). For
3 patients the bypass was performed at the end of
the operation (33%). 
After intra-arterial injection of 10,000 IU
heparin the femoral artery was punctured, and an
11F angiography sheath with a dilator (Balt,
Montmorency, France) was advanced over a Terumo
guide wire (Terumo Europe, Leuven, Belgium) and
placed at the level of the renal arteries. After removal
of the dilator, an aortogram was obtained for loca-
tion of the origin of the renal arteries and was frozen
on the fluoroscopy screen (GE Medical Systems,
Loncin, Belgium). A graduated radiopaque marker
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Fig 1. The occluding configuration of the Corvita aortic
endoluminal stent graft.
Table I. Associated pathologic conditions
Condition No. of patients
Ischemic coronary disease 9
Pulmonary insufficiency 3
Renal insufficiency (creatinine >1.8 mg/dL) 5
Hypertension 8
Previous stroke 2
was placed preoperatively under the patient on the
operating table parallel to the left border of the
patient’s lumbar spine. The angiographic sheath was
pulled down to the bifurcation. Angiography of the
aortoiliac bifurcation was performed and stored in
the computer memory. 
Length of the aortic stent graft was determined
with the aortogram and graduated marker and cor-
rected for magnification. The stent graft was cut at
the calculated length and made occlusive by means
of placement of a nonabsorbable ligature at the dis-
tal extremity or in the middle of the device (Fig 1).
After introduction of a superstiff guide wire
(Schneider, Bülach, Switzerland) the angiography
sheath was removed. The endoluminal delivery
device (ID18F600; Balt) is composed of an internal
removable holder and an outer sheath. The aortic
stent graft was introduced into the leading part of
the delivery device, which was closed over by a con-
ical flexible tip. The delivery device was loaded over
the stiff guide wire and advanced up to the aortic
position. Under fluoroscopic control with the frozen
image and radiopaque marker as guides, the distal
extremity of the delivery device was positioned just
below the renal artery bifurcation. The flexible tip
and stent graft were unloaded from the outer sheath
by means of maintaining the stent graft in the cor-
rect position with the holder and slowly retrieving
the outer sheath. Stent graft length was calculated
for the distal extremity of the stent graft to be posi-
tioned within the aortic bifurcation or within a com-
mon iliac artery. The angiographic sheath and stiff
guide wire were removed.
The maneuvers were repeated on the other side
at the level of the common iliac artery to deliver
another occluding stent graft but one that was small-
er and shorter. The hypogastric arteries were main-
tained patent for vascularization of the colon by
means of retrograde perfusion through the extra-
anatomic axillofemoral bypass. At the end of the
procedures, an angiogram was obtained to confirm
the position of the stent grafts and to verify the
absence of paraprosthetic leaks. After reversal of
heparin by means of protamine, the wounds were
closed. All patients received prophylactic antibiotic
coverage with three doses of cefazolin beginning at
induction of anesthesia. Neither anticoagulants nor
antiplatelet drugs were administered postoperatively.
Follow-up protocol. Before discharge from the
hospital, plain radiographs of the abdomen were
obtained to verify the position of the stent graft.
Color duplex flow and contrast helical CT scanning
were performed to image the stent graft and to
determine the extent of aortic aneurysmal thrombo-
sis. Patency of the axillofemoral bypass was con-
firmed by means of clinical and Doppler examina-
tions. Rectosigmoidoscopy was performed to
exclude colonic ischemic lesions in the first 48 hours
after the operation. Three, 6, 12, 18, and 24 months
after the operation the patients underwent clinical
examinations and imaging to evaluate the natural
history of the excluded AAA sac and to determine
the maximal transverse diameter of the AAA.
RESULTS
There was one postoperative death of severe
arrhythmia, metabolic acidosis, and cardiac arrest on
the second postoperative day. Two patients had a
moderate inflammatory reaction with raised erythro-
cyte sedimentation rate, increased C-reactive protein
value, and lowered platelet count beginning on the
second postoperative day and subsiding sponta-
neously 1 week later. All bacterial culture results
were negative. Three patients had cardiac ischemic
attacks in the postoperative period. One patient had
distal microembolization of the lower limbs.
Thrombectomy was not required.
Systematic rectosigmoidoscopy was performed
on the second postoperative day and demonstrated
no ischemic colonic lesions in any patients.
Postoperative CT scans showed total aortic aneurys-
mal thrombosis in 7 of the 8 surviving patients. The
one proximal paraprosthetic leak was managed suc-
cessfully by means of angiographic embolization.
One patient refused follow-up CT scans. Duplex
scanning was performed and confirmed aortic
aneurysm thrombosis at 12 months.
The mean follow-up period was 12 months with
a range of 6 to 17 months. For 2 patients the follow-
up period was 6 and 7 months, and for 6 it was more
than 12 months. The aortic aneurysmal diameter
decreased from 2 mm in 2 patients observed for 6
months to a mean of 4 mm (range 1 to 6 mm)
among the 6 patients observed for more than 12
months. All axillofemoral bypass grafts were patent
at the time of this study.
DISCUSSION
Standard surgical treatment of infrarenal aortic
aneurysm is replacement of the aneurysm by means
of direct in-line interposition with synthetic graft.
Though the overall elective operative mortality rate
is low, some authors have found the mortality rate to
be as high as 20% to 60% among patients with
comorbid conditions.12,13 Nonresective techniques
have been described such as bilateral iliac artery
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occlusion by means of ligature,14 use of metallic
clips,15 or use of a balloon catheter16 combined with
axillofemoral bypass to restore distal perfusion.
Proximal ligature of an infrarenal AAA or angio-
graphic embolization is performed to ensure total
clotting of the aneurysmal sac.15,16 Deprived of both
inflow and outflow, the aneurysm thus is expected to
undergo complete thrombosis. The operative mor-
tality rate for these nonresective techniques ranges
from 0%17 to 31%.18
Complications related to the extra-anatomic
bypass have occurred among 13%17 to 25%19,20 of
instances. Long-term patency of aortoiliac and
aortofemoral grafts may be superior to that of
axillofemoral grafts. However, in recent years excel-
lent primary patency of axillofemoral bypass grafts
has been reported.21,22 Patency of these axillo-
femoral bypass grafts seems better among patients
with aortic disease than among patients with lower
limb occlusive arterial disease. In a series of 38
patients undergoing axillofemoral bypass for aortic
graft infection, Bacourt et al23 reported an 8% graft
thrombosis rate for a group of patients treated for
aneurysms compared with 38% for a group who
underwent operations for occlusive disease.
During the past few years, transluminal manage-
ment of aortic aneurysm has been reported by a
number of investigators.7-10,24-26 Placement of the
endograft, however, is not without disadvantages. In
addition to shortness of the proximal aortic aneurys-
mal neck, which precludes this procedure, complex
aortic or aortoiliac morphologic characteristics may
render the technique difficult or hazardous. Marked
angulation of the proximal aortic aneurysmal neck
more than 80 degrees can lead to misplacement or
dislodgment of the stent, resulting in proximal leak-
age10 or to uneven opening of the device with sub-
sequent stenosis and endograft occlusion. Calcified
and tortuous distally iliac vessels may provoke kink-
ing of the endograft, which results in acute endo-
graft occlusion with subsequent acute ischemia of
the lower limbs. In these situations, delivery of a
blind endograft as proximally as possible under the
renal arteries and extending into one common iliac
artery provokes thrombosis of the entire infrarenal
aortic aneurysmal sac. This was shown on postoper-
ative CT scans for 7 of 8 surviving patients. When
residual periprosthetic leakage occurs, angiographic
embolization is performed to ensure total aortic
aneurysmal thrombosis, as occurred in one of our
patients.11 The main cause of proximal leakage is the
presence of underlying atherosclerotic disease that
caused a cobblestone surface at the arterial neck and
provoked an incomplete friction seal between the
endoluminal graft and the arterial wall.9
The contralateral common iliac artery is occlud-
ed by means of a second endograft or a surgical lig-
ature if necessary. The hypogastric arteries are main-
tained patent to assure retrograde perfusion to the
descending colon. None of our patients had colonic
ischemic lesions at systematic rectosigmoidoscopic
examinations performed on the second postopera-
tive day. Extension of the aortic thrombus to the
renal and superior mesenteric arteries has been
described after juxtarenal aortic thrombosis.27,28 In
nonresective surgical treatment of AAA, this poten-
tial complication mentioned by Berguer et al16 has
been reported in only one patient after induction of
AAA thrombosis by means of ligation of the two
common iliac arteries.29
Rupture of thrombosed aortic aneurysm, either
spontaneous or after induced maneuvers, has been
described.30,31 The rate of rupture was higher
among patients treated by means of induction of
aortic aneurysmal thrombosis (20%) compared with
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Fig 2. Aortic aneurysmal diameter decreased by 6 mm 10
months after the operation.
the total exclusion technique (6%).20,31 One hypoth-
esis for the higher rate of rupture after induced
thrombosis is incomplete occlusion of the infrarenal
aortic aneurysm so that antegrade blood flow to the
lumbar or inferior mesenteric arteries was maintained
with high pressure. In 36 case reports of postopera-
tive rupture of thrombosed aortic aneurysms that we
collected from the literature (Table II), only 4
aneurysms were shown to be totally occluded either
at angiography18,34 or postmortem autopsy.29
Ligating the proximal aortic aneurysm neck or
inducing AAA thrombosis with an occluding endolu-
minal device interrupts antegrade blood flow within
the potential outflow vessels such as inferior mesen-
teric or lumbar arteries. Retrograde filling of the
aneurysmal sac from runoff vessels may occur with
low pressure. However, in our experience, most of
these blind endoleaks thrombosed spontaneously
after 3 months of follow-up study.11
There was no postoperative aortic aneurysmal
rupture in our small series, but the follow-up period
was limited to an average of 12 months. Regression
of the aortic aneurysmal diameter 6 and 12 months
after the operation confirmed total exclusion of the
aneurysmal sac11 (Fig 2). In endoluminal manage-
ment of AAA the maximum transverse diameter of
the aneurysmal sac has proved to be reduced by 1
mm after 6 months only in blood-tight endoluminal
grafts and 6 mm after 20 months.10
CONCLUSION
Endoluminal management of infrarenal AAA has
to be explored among patients at high risk. The
method is limited by the length of the proximal neck
of the aneurysm and by morphologic features that do
not allow correct placement of the devices. For
selected patients at high risk with complex anatomic
characteristics, use of an occluding endoluminal stent
graft combined with extra-anatomic axillofemoral
bypass seems to be a good alternative. Longer-term
follow-up study is necessary to evaluate the efficacy
of endoluminal exclusion of the abdominal aortic sac.
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